Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
CD8+ T cells
HIV-1
HLA-B*67:01
protective epitope
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
23 11 2022
23 11 2022
Historique:
pubmed:
4
11
2022
medline:
26
11
2022
entrez:
3
11
2022
Statut:
ppublish
Résumé
Rare HLA alleles such as HLA-B57 are associated with slow progression to AIDS. However, the evidence for the advantage of rare protective alleles is limited, and the mechanism is still unclear. Although the prevalence of HLA-B*67:01 is only 1.2% in Japan, HLA-B*67:01-positive (HLA-B*67:01
Identifiants
pubmed: 36326273
doi: 10.1128/jvi.01248-22
pmc: PMC9683060
doi:
Substances chimiques
HLA-B Antigens
0
Epitopes
0
Epitopes, T-Lymphocyte
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0124822Références
Circ J. 2012;76(7):1697-702
pubmed: 22664757
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
pubmed: 10694578
J Virol. 2012 Apr;86(8):4082-90
pubmed: 22318135
Nat Med. 1997 Feb;3(2):212-7
pubmed: 9018241
Blood. 2010 Jun 10;115(23):4820-3
pubmed: 20385791
J Infect Dis. 2009 Feb 1;199(3):419-26
pubmed: 19115949
Nat Med. 2016 Jun;22(6):606-13
pubmed: 27183217
Rheumatology (Oxford). 2010 Apr;49(4):621-31
pubmed: 20083539
AIDS. 2014 Apr 24;28(7):959-67
pubmed: 24566094
J Virol. 2008 Sep;82(17):8548-59
pubmed: 18596105
J HIV Ther. 2003 May;8(2):36-41
pubmed: 12838163
J Virol. 2019 Mar 21;93(7):
pubmed: 30674626
AIDS. 2012 Jul 17;26(11):F21-9
pubmed: 22617051
AIDS. 1999 Oct 1;13(14):1990-1
pubmed: 10513667
Eur J Immunol. 2010 Jul;40(7):1973-84
pubmed: 20468055
J Infect Dis. 2017 Dec 12;216(11):1415-1424
pubmed: 28968792
Intern Med. 2002 Jan;41(1):44-6
pubmed: 11838591
AIDS. 2014 Jul 17;28(11):1687-90
pubmed: 24853499
J Immunol. 2008 Jan 15;180(2):1107-16
pubmed: 18178851
Transplantation. 1997 Oct 15;64(7):1017-27
pubmed: 9381524
J Virol. 2018 Feb 12;92(5):
pubmed: 29237835
PLoS One. 2008;3(12):e3907
pubmed: 19107206
Nature. 2004 Dec 9;432(7018):769-75
pubmed: 15592417
Annu Rev Med. 2003;54:535-51
pubmed: 12525683
Hum Immunol. 2001 Jun;62(6):645-50
pubmed: 11390040
Jpn Circ J. 1994 Jan;58(1):9-14
pubmed: 7908064
Virology. 2006 Aug 1;351(2):322-39
pubmed: 16684552
Immunity. 2012 Sep 21;37(3):426-40
pubmed: 22999948
Retrovirology. 2013 Dec 12;10:152
pubmed: 24330837
J Virol. 2009 Sep;83(17):8300-14
pubmed: 19439471
J Virol. 2004 Aug;78(16):8927-30
pubmed: 15280502
J R Soc Med. 2004 Jan;97(1):10-4
pubmed: 14702356
Gastroenterology. 2012 Mar;142(3):e27-8; author reply e28-9
pubmed: 22281265
Nat Med. 2007 Jan;13(1):46-53
pubmed: 17173051
AIDS. 2012 Jan 28;26(3):275-84
pubmed: 22095198
Hum Immunol. 2013 Dec;74(12):1636-42
pubmed: 24012585
Science. 1999 Mar 12;283(5408):1748-52
pubmed: 10073943
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
J Immunol. 2011 Jan 1;186(1):479-88
pubmed: 21115730
Mol Ther. 2014 Feb;22(2):464-475
pubmed: 24166483
PLoS One. 2007 Oct 03;2(10):e984
pubmed: 17912361
J Virol. 2015 May;89(10):5330-9
pubmed: 25741000
J Immunol. 2006 Oct 1;177(7):4699-708
pubmed: 16982909
Int J Rheum Dis. 2014 Mar;17(3):238-47
pubmed: 24548718
J Virol. 2020 Sep 15;94(19):
pubmed: 32699092
Intern Med. 1996 Jul;35(7):521-2
pubmed: 8842753
J Immunol. 2004 Oct 1;173(7):4607-17
pubmed: 15383595
J Virol. 2012 Oct;86(19):10870-2
pubmed: 22811530
Nat Med. 2003 Jul;9(7):928-35
pubmed: 12819779
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
Nat Med. 1996 Apr;2(4):405-11
pubmed: 8597949
J Virol. 2013 Apr;87(7):4043-51
pubmed: 23365442
PLoS One. 2010 Mar 10;5(3):e9629
pubmed: 20224785
J Immunol. 1991 Sep 1;147(5):1512-21
pubmed: 1715361
Nature. 2015 Jan 15;517(7534):381-5
pubmed: 25561180
J Virol. 2010 Oct;84(19):9879-88
pubmed: 20660184
Trends Mol Med. 2001 Sep;7(9):379-81
pubmed: 11530315
J Virol. 2010 Nov;84(22):11937-49
pubmed: 20810731
Tissue Antigens. 1993 Aug;42(2):87-90
pubmed: 7903491
Arthritis Rheumatol. 2015 May;67(8):2226-32
pubmed: 25931203
PLoS Pathog. 2007 Nov;3(11):e157
pubmed: 18052528
J Virol. 2012 Sep;86(18):9802-16
pubmed: 22761389
Microbes Infect. 2008 Jun;10(7):764-72
pubmed: 18538615
J Virol. 2007 Mar;81(5):2440-8
pubmed: 17182686
J Virol. 2018 Dec 10;93(1):
pubmed: 30333175
Immunity. 2008 Jun;28(6):822-32
pubmed: 18549801
J Virol. 2006 Apr;80(7):3617-23
pubmed: 16537629
J Clin Invest. 1998 Nov 1;102(9):1758-65
pubmed: 9802890
Tissue Antigens. 2007 Jan;69(1):73-85
pubmed: 17212710
J Virol. 2014 May;88(9):4764-75
pubmed: 24522911
J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1318-23
pubmed: 15385741
J Virol. 2000 Jun;74(12):5679-90
pubmed: 10823876
J Virol. 2008 Jun;82(11):5398-407
pubmed: 18353945
J Virol. 2012 Nov;86(22):12013-24
pubmed: 22933291
Retrovirology. 2018 Jul 3;15(1):46
pubmed: 29970102
PLoS Genet. 2009 Dec;5(12):e1000791
pubmed: 20041166
Tissue Antigens. 2009 Jan;73(1):17-32
pubmed: 19000140
Hum Immunol. 2001 Sep;62(9):1009-30
pubmed: 11543903
AIDS. 2007 Jan 11;21(2):135-43
pubmed: 17197803